Fortress Biotech (FBIO)

Fortress Biotech (FBIO) Financial Statements


Fortress Biotech Financial Overview

Fortress Biotech's market cap is currently ―. The company's EPS TTM is $-0.986; its P/E ratio is -0.73; Fortress Biotech is scheduled to report earnings on May 11, 2023, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 22Jun 22Mar 22Dec 21Sep 21
Income Statement-
Total Revenue$ 16.53M$ 18.89M$ 23.93M$ 18.28M$ 21.09M
Gross Profit$ 9.31M$ 11.25M$ 15.72M$ 8.75M$ 9.92M
EBIT$ -50.22M$ -51.33M$ -47.52M$ -64.41M$ -42.14M
EBITDA$ -47.88M$ -49.11M$ -45.32M$ -62.73M$ -40.40M
Net Income Common Stockholders$ -22.51M$ -21.36M$ -15.76M$ -31.57M$ -20.78M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 208.35M$ 248.77M$ 287.51M$ 305.74M$ 252.72M
Total Assets$ 323.56M$ 363.95M$ 407.93M$ 396.50M$ 407.83M
Total Debt$ 125.41M$ 118.97M$ 118.72M$ 74.98M$ 84.56M
Net Debt$ -82.94M$ -129.80M$ -168.79M$ -230.77M$ -168.16M
Total Liabilities$ 222.21M$ 216.25M$ 214.35M$ 170.63M$ 195.37M
Stockholders Equity$ 61.67M$ 77.22M$ 97.86M$ 108.67M$ 92.66M
Cash Flow-
Free Cash Flow$ -44.29M$ -41.73M$ -48.20M$ -42.20M$ -29.24M
Operating Cash Flow$ -43.27M$ -41.42M$ -46.86M$ -38.70M$ -21.70M
Investing Cash Flow$ -893.00K$ -307.00K$ -21.34M$ 53.35M$ -7.54M
Financing Cash Flow$ 3.75M$ 2.99M$ 49.96M$ 38.94M$ 6.97M
Currency in USD

Fortress Biotech Earnings and Revenue History

Fortress Biotech Debt to Assets

Fortress Biotech Cash Flow

Fortress Biotech Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis